SK PHARMTECO
Live / Registered — Registered (as of 16 Feb 2021)
What this means for you
Registered since 16 Feb 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88740759
- Registration number
- 6269493
- Mark type
- Design + words
- Filed
- 27 Dec 2019
- Published for opposition
- 01 Dec 2020
- Registered
- 16 Feb 2021
- Attorney of record
- Hun Joon Kim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; dietetic food supplements, namely, dietetic foods adapted for medical purposes, dietetic food adapted for veterinary use; sanitary preparations for medical purposes; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; Preparations of trace elements for human and animal use, namely, nutritional supplements; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for sanitary use; Pharmaceutical preparations, namely, immunomodulators; vitamin preparations; vaccines; Dietary and nutritional supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; bacteriological preparations for medical and veterinary use
Owner
- SK INC., SEOUL, KR
- SK HOLDINGS CO., LTD, Seoul, KR
- SK HOLDINGS CO., LTD, Seoul, KR
- SK HOLDINGS CO., LTD, Seoul, KR
Prosecution history
- 16 Feb 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 06 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Dec 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jul 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Feb 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Dec 2020 — PUBLISHED FOR OPPOSITION
- 11 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE